Matches in Nanopublications for { ?s ?p "[Inhibition of BCR-ABL and RIN1 interaction using exogenous modified BCR-ABL SH3 domain provides a feasible and alternative option of small molecule inhibitors for CML treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Inhibition of BCR-ABL and RIN1 interaction using exogenous modified BCR-ABL SH3 domain provides a feasible and alternative option of small molecule inhibitors for CML treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of BCR-ABL and RIN1 interaction using exogenous modified BCR-ABL SH3 domain provides a feasible and alternative option of small molecule inhibitors for CML treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293457.RAYoAKV3LoaWMhWoHYY6tkF3OWWoNb8Vn7_aXrj-xNMZQ130_assertion description "[Inhibition of BCR-ABL and RIN1 interaction using exogenous modified BCR-ABL SH3 domain provides a feasible and alternative option of small molecule inhibitors for CML treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293457.RAYoAKV3LoaWMhWoHYY6tkF3OWWoNb8Vn7_aXrj-xNMZQ130_provenance.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion description "[Inhibition of BCR-ABL and RIN1 interaction using exogenous modified BCR-ABL SH3 domain provides a feasible and alternative option of small molecule inhibitors for CML treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_provenance.